StageAcquired | Acquired
Vidacare is a provider of intraosseous (IO), or inside the bone, access devices. Vidacare products incorporate a patented power driver and needle system to access the intraosseous space for a variety of medical, diagnostic and therapeutic purposes. Their products include the EZ-IO Intraosseous Vascular Access System, the OnControl Bone Marrow System and the OnControl Bone Access System. Vidacare's devices have become the recognized technology standard and are used in a broad range of applications including vascular access, emergency medicine, oncology and spinal surgery. On December 2nd, 2013, Vidacare was acquired by Teleflex Medical.
Missing: Vidacare's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Vidacare's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Vidacare
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Vidacare is included in 1 Expert Collection, including Medical Devices.
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Vidacare has filed 62 patents.
Medical equipment, Male suicides, Surgical instruments, Dosage forms, Testicular cancer survivors
Medical equipment, Male suicides, Surgical instruments, Dosage forms, Testicular cancer survivors
Latest Vidacare News
Aug 16, 2021
Intraosseous Devices Market Latest Industry Trends, Emerging Demands, Business Prospects 2026 Intraosseous Devices market players – Pyng Medical Corp., PerSys Medical, Aero Healthcare, Vidacare Corporation, Carefusion Inc, among others represent the global Intraosseous Devices market. The market study depicts an extensive analysis of all the players running in the Intraosseous Devices market report based on distribution channels, local network, innovative launches, industrial penetration, production methods, and revenue generation. Further, the market strategies and mergers & acquisitions associated with the players are enclosed in the Intraosseous Devices market report. Future Market Insights, in its latest business report, elaborates on the current situation of the global Intraosseous Devices market in terms of volume, value, production, and consumption. The report scrutinizes the market into various segments, end uses, regions, and players on the basis of demand patterns, and future prospects. Understanding the Impact of Covid-19 on Healthcare Industry With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance. The FMI’s latest report on the Intraosseous Devices market gives a detailed analysis on the impact of COVID-19 with an incisive coverage on the innovative strategies adopted by the market players to survive the challenges due to pandemic. Request For Table Of Content @ https://www.futuremarketinsights.com/toc/rep-gb-1516 Report Highlights: Any Queries, Contact Us @ https://www.futuremarketinsights.com/askus/rep-gb-1516 Critical Questions Answered in the Report What are ongoing trends that will shape market growth curve for global Intraosseous Devices market? What are the drivers and challenges affecting the Intraosseous Devices market demand? What are the recent technological advancement in the Intraosseous Devices market? What are key trends and opportunities that will prevail the revenue growth of Intraosseous Devices market players? How will evolving regulatory policies impact the market growth? What is the impact of Covid-19 on the Intraosseous Devices market? Reasons to Buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Why Future Market Insights? Detailed insights of market segments and sub-segments for historical as well as forecast period A competitive analysis of prominent players and emerging players in the Intraosseous Devices market Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape Home Respiratory Therapy Market – Home Respiratory Therapy Market: Global Industry Analysis 2015 – 2019 and Opportunity Assessment 2020 – 2030 Plasma-derived Protein Therapies Market – Plasma-derived Protein Therapies Market: Global Industry Analysis 2015 – 2019 and Opportunity Assessment 2020 – 2030 Olaparib API Market – Olaparib API Market: Global Industry Analysis 2015 – 2019 and Opportunity Assessment 2020 – 2030 About FMI Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact
Vidacare Frequently Asked Questions (FAQ)
When was Vidacare founded?
Vidacare was founded in 2001.
Where is Vidacare's headquarters?
Vidacare's headquarters is located at 4350 Lockhill Selma Rd, San Antonio.
What is Vidacare's latest funding round?
Vidacare's latest funding round is Acquired.
How much did Vidacare raise?
Vidacare raised a total of $18.7M.
Who are the investors of Vidacare?
Investors of Vidacare include Teleflex, Telegraph Hill Partners, Piper Sandler, Greer Capital Advisors, Targeted Technology and 5 more.
Who are Vidacare's competitors?
Competitors of Vidacare include CardioFocus, Simbionix, Svelte Medical Systems, GENICON, HydroCision and 11 more.
Compare Vidacare to Competitors
Softscope Medical Technologies is developing a medical technology designed to facilitate the performance of endoscopic procedures.
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
USGI Medical is committed to the development of technologies that enable incisionless procedures which help patients return to normal activities and lifestyles faster compared to traditional laparoscopic and open surgery.
Spectrum Medical is a manufacturer of oxygen saturation devices that are used in ECMO and Open Heart Surgery. Spectrum Medical supplies Clinical Information Solutions that include Medical Device Connectivity Technologies, Electronic Medical Record Systems, Telemedicine Capabilities and Compliance and Patient Safety Solutions. Spectrum Medical also supplies Non-invasive Diagnostics Systems for extracorporeal procedures. The company was founded in 2007 and is based in Gloucester, England.
CardioFocus manufactures medical devices dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF). Its HeartLight Endoscopic Ablation System incorporates a compliant balloon and an endoscope to provide physicians to help see within the heart and visually direct the application of laser energy to achieve durable pulmonary vein isolation. The company was founded in 1990 and is based in Marlborough, Massachusetts.
HydroCision is a developer, manufacturer, and marketer of fluid-jet based surgical tools for the spine market. Incorporated in 1994, HydroCision's fluidjet technology is the basis of a new surgical modality leveraging compelling features and offering application versatility. The company is developing a broad range of fluidjet-based products to meet the needs of spine specialists.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.